Literature DB >> 20848662

Taqman genotyping assays can be used on decalcified and paraffin-embedded tissue from patients with osteosarcoma.

Melanie M Hagleitner1, Marieke J H Coenen, Judith W M Jeuken, Uta Flucke, H W Bart Schreuder, D Maroeska W M te Loo, Peter M Hoogerbrugge.   

Abstract

BACKGROUND: In cancers like osteosarcoma with a 5-year overall survival of 50-60%, archived histological specimens can be a useful source of biological material. However, this material generally has been decalcified and formalin-fixed for many years. In our study, we investigated whether DNA obtained from these tissues can be used for reliable single nucleotide polymorphism (SNP) genotyping. PROCEDURE: We studied two SNPs in the drug transporter MDR1 using Taqman® SNP genotyping assays. Genotypes of the germ line DNA derived from freshly isolated DNA of 20 surviving patients with osteosarcoma were compared with genotypes obtained from archived material from decalcified formalin-fixed, paraffin-embedded (FFPE) blocks of the same patients.
RESULTS: Decalcified FFPE-derived DNA yielded smaller PCR fragments compared to DNA extracted from peripheral blood cells, with a reliable size of ∼200 bp. However, we were able to evaluate each SNP in 19 of 20 cases included in this study. All successfully genotyped samples showed 100% concordance between genotypes obtained from DNA of FFPE tissue and the genotypes obtained from DNA of blood from the same patients.
CONCLUSIONS: In conclusion, we have demonstrated that decalcified FFPE tissue can be used for genetic polymorphism analysis using Taqman® allelic discrimination assays. This forms a unique opportunity to combine new insights in genetic research with historical patient cohorts.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848662     DOI: 10.1002/pbc.22654

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.

Authors:  Daniel L Hertz; Kelley M Kidwell; Jacklyn N Thibert; Christina Gersch; Meredith M Regan; Todd C Skaar; N Lynn Henry; Daniel F Hayes; Catherine H Van Poznak; James M Rae
Journal:  Mol Oncol       Date:  2015-07-29       Impact factor: 6.603

2.  Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population.

Authors:  Ai-Lin Li; Yong-Xi Song; Zhen-Ning Wang; Peng Gao; Yuan Miao; Jin-Liang Zhu; Zhen-Yu Yue; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

3.  The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis.

Authors:  Yong-Xi Song; Xin Zhou; Zhen-Ning Wang; Peng Gao; Ai-Lin Li; Ji-Wang Liang; Jin-Liang Zhu; Ying-Ying Xu; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

4.  Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Authors:  Melanie M Hagleitner; Marieke J H Coenen; Ana Patino-Garcia; Eveline S J M de Bont; Anna Gonzalez-Neira; Hanneke I Vos; Frank N van Leeuwen; Hans Gelderblom; Peter M Hoogerbrugge; Henk-Jan Guchelaar; Maroeska W M Te Loo
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

5.  Discrepancies between VEGF -1154 G>A polymorphism analysis performed in peripheral blood samples and FFPE tissue.

Authors:  Giorgia Marisi; Alessandro Passardi; Daniele Calistri; Wainer Zoli; Dino Amadori; Paola Ulivi
Journal:  Int J Mol Sci       Date:  2014-07-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.